semaglutide cyano FBI warns about counterfeit weight
Description
Retrieved 2023-10-05.
Hence, it is unclear whether the lack of CV benefit with oral semaglutide is attributed to its formulation or secondary to selection bias
2000;278(6):G946G951
Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, van Raalte DH (2017) GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
doi: 10.2337/db22-338-OR
The logic is straightforward: cagrilintide activates amylin receptors while tirzepatide activates GLP-1 and GIP receptors
